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Introduction {#sec005}
============

Polypoidal choroidal vasculopathy (PCV) is an important form of maculopathy among Asian elderly \[[@pone.0226763.ref001]--[@pone.0226763.ref003]\], and it manifests as orange-reddish, polypoidal structures at the posterior pole \[[@pone.0226763.ref004]\]. Indocyanine green angiography (ICGA) is a gold standard to diagnose PCV and characterized by a network of vessels with two distinct components: a complex of branching vessels and multiple, terminal, polypoidal lesions \[[@pone.0226763.ref005]--[@pone.0226763.ref008]\].

Previous studies showed strong associations between the lipid metabolism associated genes including the hepatic lipase (LIPC) locus rs10468017, lipoprotein lipase (LPL) locus rs10468017 and cholesterol ester transfer protein (CETP) based on the drusen that is a mound between the RPE cell and its basement membrane and mainly consist of liquids and the development of age-related macular disease (AMD) \[[@pone.0226763.ref009]--[@pone.0226763.ref011]\]. These discoveries in the lipid pathway provided new insight into the pathogenesis of AMD, although other studies have found no association with AMD \[[@pone.0226763.ref012],[@pone.0226763.ref013]\]. However, there are limited and inconsistent results evaluating the association between the lipid-associated genes and the development of PCV.

A change of plasma lipid/lipoproteins concentration is considered to be one of the risk factors of PCV development. A clinical trial suggests lower low-density cholesterol (LDL), is a protective factor for PCV, whereas higher high-density lipoprotein (HDL) levels and an increased risk of PCV \[[@pone.0226763.ref010]\]. In contrast, an epidemiological study report that higher HDL level is associated with a lower risk of PCV and there are no evident associations between LDL or total cholesterol and PCV \[[@pone.0226763.ref013]\]. To date, there are limited data to analyze apolipoprotein concentrations and epidemiological results of association between serum lipid biomarkers and PCV are inconsistent. Therefore, it is necessary to acquire more evidence to distinguish that the role of lipid/lipoproteins concentrations in the development of PCV.

What's more, although several studies reported that drusen was frequently seen in PCV eyes and it is a vascularized complication \[[@pone.0226763.ref014]\], there are limited reports comprehensively evaluating the association of the lipid metabolism and genetic variants with the development of PCV, especially in Asian population.

Thus, we performed this study to comprehensively analyze the role of gene variations in the HDL cholesterol metabolic pathway and firstly delineate the systemic risk factors, serum levels including high-density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol (TC), triglycerides (TG), apolipoprotein A1 (APOA1) and apolipoprotein B (APOB) and genetic variants in the HDL metabolic pathway in cases and controls to further evaluate the lipid-PCV association in China population.

Materials and methods {#sec006}
=====================

Subjects {#sec007}
--------

A total of 216 unrelated Chinese participants were enrolled in this case-control cohort from January 2018 to December 2018; specifically, 66 patients had PCV, and 150 individuals without age-related maculopathy (ARM) were studied as controls. The study subjects were recruited from the Department of Ophthalmology of Peking University People's Hospital, and the study was approved by the Ethical Committee of Peking University People's Hospital. An informed consent process was established following the guidelines of the Helsinki Declaration, and all subjects signed consent forms. All subjects received a standard ophthalmic examination, including visual acuity, slit-lamp biomicroscopy, and dilated fundus examinations, performed by two retinal specialists to avoid potential diagnosis bias. All cases with PCV underwent fluorescein angiography, optical coherence tomography (OCT), and indocyanine green angiograms with HRA2 (Heidelberg Engineering, Heidelberg, Germany). The diagnosis of PCV was based on indocyanine green angiography (ICGA) results, which showed a branching vascular network that terminated in aneurysmal enlargements. Exclusion criteria included any eye with any other macular abnormalities, such as pathological myopia, presumed ocular histoplasmosis, idiopathic choroidal neovascularization (CNV), and other secondary CNV (diabetic retinopathy). Normal controls were defined as having no clinical evidence of macular disease in any eyes, excluding subjects with severe cataracts to avoid choose bias. Data on hypertension, diabetes mellitus (DM), hyperlipidemia, asthma and coronary artery disease (CAD) was acquired by a questionnaire.

Serum analysis {#sec008}
--------------

Fasting serum samples were collected on the same day (January 2018 to December 2018) as the ophthalmic examinations and were analyzed for TC, TG, HDL and LDL, APOA1, APOB, respectively, in the clinical laboratory at the Peking University People's Hospital. Authors have terminal system to check patient blood examinations results.

Genetic analysis {#sec009}
----------------

Blood samples were collected once participants clearly diagnosed and stored at -80°C before DNA extraction. Genomic DNA was extracted from venous blood leukocytes using a genomic extraction kit (Beijing eBios Biotechnology Co., Ltd.), and genotyping was performed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), as previously described \[[@pone.0226763.ref015]\]. Briefly, approximately 30 ng of genomic DNA was used to genotype each sample. The DNA samples were amplified, and the PCR products were used for locus-specific single-base extension reactions. The resulting products were desalted and transferred to a 384 SpectroCHIP array (Sequenom, San Diego, CA, USA). Allele detection was performed using MALDI-TOF-MS. The mass spectrograms were analyzed using MassARRAY Typer software version 4.0 (Sequenom, San Diego, CA, USA). Genotyping was performed on January 2019 and authors had reports of every subject to identify individual participants during or after data collection.

Statistical analysis {#sec010}
--------------------

The data were analyzed using SPSS (version 16.0; SPSS Science, Chicago, IL). All SNPs were assessed for Hardye Weinberg equilibrium (HWE) using chi-square tests. Differences in systemic risk factors, alleles and genotypes frequencies were assessed using chi-squared tests and serum lipids levels were analyzed by unpaired Student's t-tests between cases and controls. We analyzed the association between PCV and systemic risk factors, serum lipids and genetic variants (allele and genotypes frequencies) using logistic regression models to estimate the odds ratios (ORs) with 95% confidence intervals (CIs). We also determined the mean levels of serum lipids according to 4 SNPs genotype using ANOVA (post hoc Bonferroni test) and Student's t-tests. P\<0.05 were considered to be statistically significant.

Results {#sec011}
=======

Of all the participants (216 cases), 66 were PCV patients (mean age of 69.89±9.18 years, 53.0% males), and 150 were the controls (mean age of 69.49±9.00 years, 44.0% males). Demographic characteristic of the study population are shown in [Table 1](#pone.0226763.t001){ref-type="table"}.Patients with PCV were more likely to suffer from hyperlipidemia (P\<0.001). No association of age, gender hypertension, CAD, diabetes, and asthma with PCV was found (P\>0.05). In multivariable analysis given in [Table 2](#pone.0226763.t002){ref-type="table"}, the remained significant factors were hyperlipidemia (OR = 1.19, P = 0.001) and other factors were still not statistically significant.

10.1371/journal.pone.0226763.t001

###### Systemic risk factors analysis between PCV and control.

![](pone.0226763.t001){#pone.0226763.t001g}

  -----------------------------------------------------------
                          PCV          Control      P
  ----------------------- ------------ ------------ ---------
  Age                                               0.761\

  Mean±SD                 69.89±9.18   69.49±9.00   

  Gender, n (%)                                     0.220

  Male                    35 (53.0)    66 (44.0)    

  Female                  31 (47.0)    84 (56.0)    

  Hypertension, n (%)     32 (48.5)    92 (61.3)    0.079

  Hyperlipidemia, n (%)   6 (9.1)      51 (34.0)    \<0.001

  Coronary artery         6 (9.1)      26 (17.3)    0.116

  disease, n (%)                                    

  Diabetes, n (%)         12 (18.2)    28 (18.7)    0.933

  Asthma, n (%)           2 (3.0)      4 (2.7)      0.867
  -----------------------------------------------------------

10.1371/journal.pone.0226763.t002

###### Systemic risk factors analysis by logistic regression.

![](pone.0226763.t002){#pone.0226763.t002g}

                            PCV (n = 66) vs. Control (n = 150)
  ------------------------- ------------------------------------
  Age                       0.86        1.00 (0.97,1.04)
  Gender                    0.245      0.69 (0.37,1.29)
  Hypertension              0.583      0.83 (0.42,1.62)
  Hyperlipidemia            0.001      1.19 (1.07,1.51)
  Coronary artery disease   0.204      0.51 (0.18,1.44)
  Diabetes                  0.137      1.94 (0.81,4.65)
  Asthma                    0.755      0.75 (0.13,4.51)

The serum lipid levels of the cases and controls are provided in [Table 3](#pone.0226763.t003){ref-type="table"}. In univariate analysis, patients with PCV had significantly lower levels of HDL and LDL (1.16 vs. 1.31 mmol/L, P = 0.001 and 2.72 vs. 3.11 mmol/L, P = 0.002). The APOA1 and APOB levels were significant lower in patients than the controls (P\<0.001). In addition, in multivariable analysis ([Table 4](#pone.0226763.t004){ref-type="table"}), HDL, LDL, APOB levels were remained to be associated with PCV (OR = 0.001, P = 0.004; OR = 0.099, P = 0.010; OR = 0.839, P = 0.018; OR = 0.000, P = 0.000) while APOA1 levels were no longer significant. Nevertheless, higher levels of TC tended to be potently associated with increased risk of PCV (OR = 109.8, P = 0.000). Other factors were not statistically significant.

10.1371/journal.pone.0226763.t003

###### Levels of serum lipids analysis between PCV and controls.

![](pone.0226763.t003){#pone.0226763.t003g}

                  PCV            Control        P
  --------------- -------------- -------------- ---------
  Age                                           0.761
  Mean±SD         69.89±9.18     69.49±9.00     
  Gender, n (%)                                 0.220
  Male            35 (53.0)      66 (44.0)      
  Female          31 (47.0)      84 (56.0)      
  HDL (mm/L)      1.16±0.29      1.31±0.32      0.001
  LDL (mm/L)      2.72±0.91      3.11±0.81      0.002
  TC (mm/L)       4.82±1.05      5.11±0.95      0.050
  TG (mm/L)       1.72±0.82      1.65±1.09      0.641
  APOA1 (mg/dl)   131.24±19.36   143.06±19.36   \<0.001
  APOB (mg/dl)    88.39±24.66    100.73±21.13   \<0.001

10.1371/journal.pone.0226763.t004

###### Levels of serum lipids analysis by logistic regression.

![](pone.0226763.t004){#pone.0226763.t004g}

                  PCV (n = 66) vs. Control (n = 150)
  --------------- ------------------------------------
  Age             0.341        0.98 (0.93,1.02)
  Gender          0.357        0.61 (0.20,1.76)
  HDL (mm/L)      0.004        0.001 (0.000,0.106)
  LDL (mm/L)      0.010        0.099 (0.017,0.569)
  TC (mm/L)       0.000        109.8 (1.65, 1249.9)
  TG (mm/L)       0.079        0.43 (0.171,1.10)
  APOA1 (mg/dl)   0.403        0.974 (0.917,1.035)
  APOB (mg/dl)    0.018        0.839 (0.839,0.984)

Next, SNPs statistics were analyzed in 66 patients with PCV compared with 150 controls except rs173539 (66 cases and 147 controls). [Table 5](#pone.0226763.t005){ref-type="table"} and [Table 6](#pone.0226763.t006){ref-type="table"} gave details of genotype and allele frequencies statistics. All 4 SNPs showed no significant deviation from HWE in the control and PCV group (P\>0.05), except rs173539 in the PCV group (P\<0.01). We found that the risk allele frequency of LIPC rs10468017 was significantly associated with PCV in the patients with PCV (P = 0.000, OR = 11.68). However, the frequency of the minor allele of CETP rs3764261 tended to be a protective role (P = 0.000, OR = 0.08). CETP rs173539 and LPL rs12678919 did not show significant associations with the development of PCV (P\>0.05). Interestingly, The homozygosity of risk alleles (Genotype) for 4 SNPs conferred no association of PCV (P\>0.05).

10.1371/journal.pone.0226763.t005

###### Allele frequency associations analysis.

![](pone.0226763.t005){#pone.0226763.t005g}

  Gene   SNP          Allele   PCV        Control   P[^a^](#t005fn001){ref-type="table-fn"} Value   P[^b^](#t005fn002){ref-type="table-fn"} Value
  ------ ------------ -------- ---------- --------- ----------------------------------------------- -----------------------------------------------
  LIPC   rs10468017   T        28    65   0.000     0.000                                           11.68(4.16,32.82)
  CETP   rs3764261    T        27    48   0.485     0.000                                           0.08(0.03,0.25)
         rs173539     T        4    12    0.850     0.599                                           0.73(0.23,2.32)
  LPL    rs12678919   G        8    21    0.901     0.356                                           1.61(0.58,4.45)

P^a^. chi-square test

P^b^. logistic regression test

10.1371/journal.pone.0226763.t006

###### Genotype frequency associations analysis.

![](pone.0226763.t006){#pone.0226763.t006g}

  Gene   SNP          Genotype   PCV   Control   P[^a^](#t006fn001){ref-type="table-fn"} Value   P[^b^](#t006fn002){ref-type="table-fn"} Value   OR (95%CI)   
  ------ ------------ ---------- ----- --------- ----------------------------------------------- ----------------------------------------------- ------------ -----------------
  LIPC   rs10468017   CC         CT    TT        41/22/3    89/57/4                              0.660                                           0.982        1.00(0.58,1.76)
  LPL    rs12678919   AA         AG    GG        58/8/0    129 /21/0                             0.000                                           0.721        0.84(0.33,2.14)
  CETP   rs173539     CC         CT    TT        64/0/2    141/0/6                               1.000                                           0.710        0.86(0.38,1.93)
         rs3764261    GG         GT    TT        40/25/1    104/44/2                             0.453                                           0.832        0.77(0.07,8.72)

P^a^. chi-square test

P^b^. logistic regression test

Finally, we explored the mean levels of serum lipids according to LIPC genotype (CC, CT, TT) and CETP genotype (GG, GT, TT). As seen in [Table 7](#pone.0226763.t007){ref-type="table"}, mean level of HDL increased with each T allele of the CETP gene (p = 0.026). Mean level of HDL was 1.24 mm/L (±0.31) for the GG genotype and 1.66 mg/L (±0.54) for the TT genotype. Additionally, mean level of APOA1 increased with each T allele of the LIPC gene (Mean level of APOA1 was 136.78 mg/dl (±20.53) for the CC genotype and 149.57 mg/dl (±22.67) for the TT genotype) and CETP gene (137.91 mg/dl (±20.36) for the GG genotype and 162.67 mg/dl (±22.50) for the TT genotype). LDL, total cholesterol triglycerides and APOB were not significantly associated with LIPC and CETP.

10.1371/journal.pone.0226763.t007

###### Associations of serum lipids with LIPC and CETP genotypes.

![](pone.0226763.t007){#pone.0226763.t007g}

                  LIPC rs10468017   CETP rs3764261                                                                       
  --------------- ----------------- ---------------- -------------- ------- -------------- -------------- -------------- -------
  HDL (mm/L)      1.23±0.31         1.31±0.33        1.33±0. 36     0.134   1.24±0.31      1.30±0.32      1.66±0.54      0.026
  LDL (mm/L)      3.01±0.88         2.99±0.82        2.52±0.93      0.341   2.97±0.89      3.02±0.80      2.97±0.60      0.908
  TC (mm/L)       4.98±0.99         5.11±0.96        4.80±1.15      0.545   4.98±0.98      5.09±1.03      5.29±0.45      0.629
  TG (mm/L)       1.62±0.82         1.75±1.28        1.69±0.91      0.660   1.61±0.95      1.81±1.14      1.36±0.46      0.351
  APOA1 (mg/dl)   136.78±20.53      142.94±18.44     149.57±22.67   0.031   137.91±20.36   141.65±18.81   162.67±22.50   0.034
  APOB (mg/dl)    96.35±23.08       98.60±22.87      89.71±22.17    0.552   96.47±23.15    97.99±22.99    96.33±12.43    0.902

Discussion {#sec012}
==========

In our study, a significant association was found between hyperlipidemia and PCV, whereas other factors including age, gender, hypertension, CAD, diabetes and asthma were not associated with PCV. We found that hyperlipidemia conferred an increased risk for PCV (OR = 1.19, P = 0.001), which is consistent with our previous published data \[[@pone.0226763.ref016]\]. However, there was result that no significant difference in hyperlipidemia between PCV and AMD \[[@pone.0226763.ref016]\]. Previous literature revealed that males are prone to suffer PCV than females \[[@pone.0226763.ref017],[@pone.0226763.ref018],[@pone.0226763.ref019]\]. Our study showed the result of all the 66 cases, 35 participants were male PCV patients (53.0%) and 66 were the male controls (44.0%). Gender was not significantly associated with PCV. We consider that this discrepancy could result from sample size of ethnic group. Other that, the associations between hypertension, CAD, DM, asthma and PCV have been inconsistent \[[@pone.0226763.ref020],[@pone.0226763.ref021]\]. Interestingly, PCV is featured by the formation of a branching vascular network (BVN) and polypoidal dilated lesions at vessel termini \[[@pone.0226763.ref022]\]. The spontaneous rupture of these polypoidal dilations may result in subretinal hemorrhages (SRH) and an abrupt decrease in the visual acuity. We speculated that blood pressure is associated with the formation of polypoidal dilated lesions and vascular rupture. Many study results in agreement with this hypothesis, especially recurrent SRH \[[@pone.0226763.ref023],[@pone.0226763.ref024]\]. However, our research has come to the opposite conclusion and previous study showed hypertension has no significant association with the development of PCV \[[@pone.0226763.ref025]\]. Thus, the role of hypertension played in the pathogenesis of PCV merit further investigations through larger randomized studies. Compared with studies on AMD, there are fewer researches on risk factors of PCV that mainly has a high prevalence in Asian countries. Thus, a multi-center study needs to be further performed to confirm the role of gender and other systemic risk factors in the development of PCV. We found that CAD, DM and asthma conferred no risk for PCV whereas other data showed different results \[[@pone.0226763.ref010],[@pone.0226763.ref017]\]. Hyperlipidemia is a known risk factor for CAD and it increases the incidence of PCV according to our results, which reminds that the ethnicity sample size needs to be expanded for further research. There is little research about asthma and the role of asthma remains to be determined.

There are growing data to study the participation of lipid metabolism in AMD pathogenesis. They evaluated that photoreceptors supplied RPE with an influx of lipids to generate ATP and damaged mitochondria lose the capacity to generate ATP \[[@pone.0226763.ref026]\]. It is warranted to collect more evidences to reflect the relationship between the level of serum lipids and the PCV. We found that higher serum level of HDL and LDL were protective factors of PCV and higher level of LDL was negatively associated with PCV. Many studies that investigated the association between PCV and HDL have been not consistent. Higher HDL levels reported to be positively associated in some studies while others reported decreased PCV risk \[[@pone.0226763.ref010],[@pone.0226763.ref013]\]. Likewise, the strength of such relevance between LDL levels and PCV is also widely variable. Chen et al reported serum levels of LDL did not reach statistical significance in patients with PCV compared to the controls \[[@pone.0226763.ref013]\]. The results data on the association of HDL and LDL are controversial. Generally, HDL is helpful the prevention of atherosclerosis and coronary heart disease. LDL is a carrier of cholesterol, which is transported to tissues, and HDL is a convert. High LDL directly promotes atherosclerosis. We speculated that the function difference of lipids in retina and it is warranted to conduct a larger sample size research to analyze the point. Additionally, we identified that the serum TC levels was a strongly risk factor. However, no significant differences were found for TC levels between the cases and controls. It is crucial to perform a larger sample size study to further confirm that the role of serum lipid levels in the development of PCV. Further, we found that the concentrations of APOA1 and APOB are parallel to HDL and LDL and the level of APOB play a protective role in PCV, which is inconsistent with previous studies \[[@pone.0226763.ref027]\]. PCV as a special type of AMD from the previous point whereas this statement should be controversial because it does not fully coincide with AMD and further research is needed. We speculated that this discrepancy might be due to different sample sizes. In a recent study \[[@pone.0226763.ref028]\], APOE and CETP genotype influenced HDL and APOA1 levels and both were significantly associated with AMD. We did take genetic polymorphism into account. LIPC, a critical enzyme, as hepatic triglyceride lipase involved in HDL metabolism \[[@pone.0226763.ref029]\]. In our analysis, the LIPC rs10468017 was associated with PCV (OR = 11.68) and level of APOA1 is increasing with allele T (P = 0.031), which is inconsistent with recent studies \[[@pone.0226763.ref013], [@pone.0226763.ref017], [@pone.0226763.ref025], [@pone.0226763.ref030]\]. That the effect of APOA1 was found by genotype classification instead of regression analysis indicated that further study is focused on genes associated with lipid metabolism.

Besides, CETP facilitates the reverse cholesterol transport by mediating the transfer of additional lipids from HDL to LDL in the systemic circulation \[[@pone.0226763.ref031]\]. In retina, CETP has the capacity to promote the maturation of HDL by transferring the oxidized lipids from the outer segments of the photoreceptors to retina pigment epithelial cells then excreted back into the system circulation \[[@pone.0226763.ref032], [@pone.0226763.ref033]\]. CETP SNP rs3764261 (the allele T) was confirmed to be significantly negatively associated with PCV whereas an association of rs173539 in CETP with PCV was not observed, which was not in consistent with many results. There were three studies indicated that CETP rs3764261 meaningfully increased the risk for PCV \[[@pone.0226763.ref013],[@pone.0226763.ref034],[@pone.0226763.ref035]\]. Further, that the apparent high levels of APOA1 and HDL are associated with T allele of CETP rs3764261 supply evidence that CETP rs3764261 play a protective role in PCV. Other else, we did not find any association of LPL rs12678919 and CETP rs173539 in allele and genotype frequency with PCV. The strength of this gene-analysis may be limited in that we just included analysis of participants in whom genetic data was available due to funding constraints. These results could provide grounds for further forward cohort research and make clinical doctors to pay attention to the risk factors exposure and evaluate the prognosis of PCV patients.

In conclusion, our study suggested that the significant associations were found between hyperlipidemia, the serum levels of TC, HDL, LDL and APOB and PCV. In addition, the LIPC rs10468017 conferred an increased risk for PCV and the CETP rs3764261 play a protective role in PCV. Serum lipids level is associated with the genotype and further research is warranted.
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